ClinicalTrials.gg
Sign In

Dyspareunia clinical trials

The registry lists 158 studies for Dyspareunia across more than 10 countries. 40 are recruiting or about to start. 81 of them are mainly about Dyspareunia (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09.

Get an email when these change. Save the Dyspareunia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
88
Recruiting
28
Status unknown
17
Not yet recruiting
11
Terminated
5
Active, not recruiting
4

Phase

Phase 3
20
Phase 2
15
Phase 4
9
Phase 1
3
Early Phase 1
3

Where

United States
56
Spain
18
Canada
16
Brazil
11
Poland
7
Turkey
7

Who runs them

Kissei Pharmaceutical Co., Ltd. (4) · Medstar Health Research Institute (3) · BC Women's Hospital & Health Centre (3) · Kanuni Sultan Suleyman Training and Research Hospital (3) · Abbott (3) · Ohio State University Comprehensive Cancer Center (3) · Riphah International University (3) · University of Sao Paulo (2)

What is being tested here

Drugs under test in Dyspareunia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Estradiol259
Testosterone113
Platelet rich plasma101
Lasofoxifene101
Linzagolix045
Dehydroepiandrosterone023
Botulinum toxin type A013
Asoprisnil003
Onabotulinum toxin A002
Lidocaine002

Drug classes tested here Estrogens 2 open · Local anesthetics 3

Coming up

1phase 3 study under way
12studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 28 Dyspareunia studies recruiting now, 11 (39%) set no upper age limit and 14 (50%) stop at 75 or younger. 1 (4%) take children under 18. 25 (89%) are for women only and 0 (0%) for men only; 8 (29%) take healthy volunteers.

Recruiting studies that take each age, of 28
AgeWomenMen
101 (4%)1 (4%)
1820 (71%)3 (11%)
3022 (79%)3 (11%)
4024 (86%)3 (11%)
5023 (82%)3 (11%)
6519 (68%)3 (11%)
7514 (50%)3 (11%)
8514 (50%)3 (11%)

Across all 158 studies, recruiting or not: 57% stop at 75 or younger and 46% at 65; 6% take children; 94% are for women only and 0% for men only; 27% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Dyspareunia studies take

Of 10 phase 3 interventional studies under Dyspareunia, half reached primary completion within 13 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 313 mo5–28 · 10 studies——
Interventional, no phase33 mo13–38 · 59 studies—33 mo14–48 · 51 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered3

Studies

Recruiting first, then most recently updated. Showing 50 of 158. Browse all 158 → or search them.